Design of functionalised circular tandem repeat proteins with longer repeat topologies and enhanced subunit contact surfaces

Commun Biol. 2021 Oct 29;4(1):1240. doi: 10.1038/s42003-021-02766-y.

Abstract

Circular tandem repeat proteins ('cTRPs') are de novo designed protein scaffolds (in this and prior studies, based on antiparallel two-helix bundles) that contain repeated protein sequences and structural motifs and form closed circular structures. They can display significant stability and solubility, a wide range of sizes, and are useful as protein display particles for biotechnology applications. However, cTRPs also demonstrate inefficient self-assembly from smaller subunits. In this study, we describe a new generation of cTRPs, with longer repeats and increased interaction surfaces, which enhanced the self-assembly of two significantly different sizes of homotrimeric constructs. Finally, we demonstrated functionalization of these constructs with (1) a hexameric array of peptide-binding SH2 domains, and (2) a trimeric array of anti-SARS CoV-2 VHH domains. The latter proved capable of sub-nanomolar binding affinities towards the viral receptor binding domain and potent viral neutralization function.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Angiotensin-Converting Enzyme 2 / metabolism*
  • COVID-19 / metabolism*
  • COVID-19 / virology
  • Computer Simulation
  • Crystallization
  • HEK293 Cells
  • Humans
  • Models, Molecular
  • Neutralization Tests
  • Protein Binding
  • Protein Domains
  • Protein Engineering / methods*
  • Protein Folding
  • Protein Structure, Secondary
  • Proteins / chemistry*
  • Proteins / metabolism*
  • SARS-CoV-2 / metabolism*
  • Spike Glycoprotein, Coronavirus / chemistry
  • Spike Glycoprotein, Coronavirus / metabolism
  • Tandem Repeat Sequences*

Substances

  • Proteins
  • Spike Glycoprotein, Coronavirus
  • spike protein, SARS-CoV-2
  • ACE2 protein, human
  • Angiotensin-Converting Enzyme 2